Validation of candidate genes associated with cardiovascular risk factors in psychiatric patients. - Wikidata - awgldk - TriplyDB

Validation of candidate genes associated with cardiovascular risk factors in psychiatric patients.

Validation of candidate genes associated with cardiovascular risk factors in psychiatric patients.

http://www.wikidata.org/entity/Q37016538

about

'Generic to genetic' transition in cardiovascular and neuropsychiatric drugs: opportunity for personalized medicine.Decreased activities of apolipoprotein m promoter are associated with the susceptibility to coronary artery diseases.

P2860

Q36421538-AF6153C6-A3CB-40ED-AB29-27FF2EFA9A50 Q37605404-AD20E212-B48D-47B6-8A27-B2935F34CCDC

P2860

Validation of candidate genes associated with cardiovascular risk factors in psychiatric patients.

http://www.wikidata.org/entity/Q37016538

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 06 August 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Validation of candidate genes ...... ctors in psychiatric patients.

@en

Validation of candidate genes ...... ctors in psychiatric patients.

@nl

type

label

Validation of candidate genes ...... ctors in psychiatric patients.

@en

Validation of candidate genes ...... ctors in psychiatric patients.

@nl

prefLabel

Validation of candidate genes ...... ctors in psychiatric patients.

@en

Validation of candidate genes ...... ctors in psychiatric patients.

@nl

P1433

Q37016538-F3FE5B40-1873-481F-9ED4-DCF4C1BECA32

P1476

Q37016538-6A1E2102-3CA1-4038-AEDC-4FB7B59588FF

P2093

Q37016538-01693879-C837-4C40-B54B-D107CB3347D4

Q37016538-10360D65-1BB5-44E3-9493-2C2B637D4A4E

Q37016538-36E08058-DC4A-4889-BAF2-42E4125B1E92

Q37016538-4086F08F-FB4E-4119-B963-861999B0D25C

Q37016538-59B88618-439D-494A-B890-A47CD0EF1E85

Q37016538-A0985F71-BF77-478E-990E-3090736ED618

Q37016538-B43CE162-C473-47E4-92B0-3BDF3BFCF9CF

Q37016538-D1FEC2B3-2578-4A2B-9B09-806D54355412

Q37016538-EEE375D9-9A54-4D45-BFEB-D4F88E1A6434

Q37016538-F96ACA2F-654B-49DA-BB6C-4BA11F25A001

P2860

Q37016538-0FE5E9F5-2A89-4010-BEA2-E69B1440546C

Q37016538-19C4BEBC-ADCF-4BD4-A697-FF6E87C202B1

Q37016538-2018C130-8CEE-4340-A9EB-C7B31778B713

Q37016538-24B5DAEB-DA67-4A73-B406-92A07AB25958

Q37016538-27CD2202-08FD-4539-A614-62570D4C1C1A

Q37016538-2819098B-5D56-45DD-9F2C-016431233B71

Q37016538-291FA720-D9E9-45CA-8511-7A9EB6690970

Q37016538-2CE7E1A2-E351-4B63-A2B5-3005B51839D0

Q37016538-34A9FD15-470F-44D6-B371-FA1702AD671A

Q37016538-363E16DC-9E08-4798-9199-9177CD14319B

P304

Q37016538-11FA8D28-F176-4F00-B669-6EF0D00BD78E

P31

Q37016538-AC5926D5-F165-495E-A98D-F9A075001C25

P356

Q37016538-673DFAC1-F1F0-4BAF-9CBF-918418D56B83

P433

Q37016538-8A9C9F1F-995A-45B1-94C8-D146AB0B34CA

P478

Q37016538-1FB28712-842E-4D8C-93AA-F9695184F52F

P50

Q37016538-45D99E5B-CE76-4E62-9695-CEC3A1C3A7A2

P577

Q37016538-88A17539-8C7C-4094-B9C5-70B50E444549

P698

Q37016538-946C087C-0198-47E0-82F5-92626EF3206A

P932

Q37016538-6577B26C-1C9B-404E-BAC3-4D0EFC105186

P356

J.PNPBP.2011.08.001

P1433

Progress in Neuro-Psychopharmacology & Biological Psychiatry

P1476

Validation of candidate genes ...... ctors in psychiatric patients.

@en

P2093

Andreas Windemuth

http://www.w3.org/2001/XMLSchema#string

Gualberto Ruaño

http://www.w3.org/2001/XMLSchema#string

Harold I Schwartz

http://www.w3.org/2001/XMLSchema#string

John W Goethe

http://www.w3.org/2001/XMLSchema#string

Jose de Leon

http://www.w3.org/2001/XMLSchema#string

Kali Bogaard

http://www.w3.org/2001/XMLSchema#string

Margaret Susce

http://www.w3.org/2001/XMLSchema#string

Mohan Kocherla

http://www.w3.org/2001/XMLSchema#string

Richard L Seip

http://www.w3.org/2001/XMLSchema#string

Stephen Woolley

http://www.w3.org/2001/XMLSchema#string

P2860

Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs

Common variants near MC4R are associated with fat mass, weight and risk of obesity

A genome-wide association study identifies a novel major locus for glycemic control in type 1 diabetes, as measured by both A1C and glucose

Six new loci associated with body mass index highlight a neuronal influence on body weight regulation

Acetyl-coenzyme A carboxylase alpha gene variations may be associated with the direct effects of some antipsychotics on triglyceride levels

A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

Newly identified loci that influence lipid concentrations and risk of coronary artery disease

A genome-wide association study identifies novel risk loci for type 2 diabetes

Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes

P304

213-219

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.PNPBP.2011.08.001

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P50

Theodore Holford

P577

2011-08-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21851846

http://www.w3.org/2001/XMLSchema#string

P932

4912220

http://www.w3.org/2001/XMLSchema#string